Adverse Reactions of Selective Serotonin Reuptake Inhibitors
- 1 January 1999
- journal article
- Published by Springer Nature in Drug Safety
- Vol. 20 (3), 277-287
- https://doi.org/10.2165/00002018-199920030-00007
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO systemEuropean Journal of Clinical Pharmacology, 1997
- Seizures and myoclonus associated with antidepressant treatment: assessment of potential risk factors, including CYP2D6 and CYP2C19 polymorphisms, and treatment with CYP2D6 inhibitorsActa Psychiatrica Scandinavica, 1997
- Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatientsInternational Clinical Psychopharmacology, 1996
- Potential Vascular and Bleeding Complications of Treatment With Selective Serotonin Reuptake InhibitorsPsychosomatics, 1996
- Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.BMJ, 1993
- A double‐blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patientsActa Psychiatrica Scandinavica, 1993
- Pharmacological Agents Affecting EmesisDrugs, 1992
- The Importance of Adverse Reactions in Drug RegulationDrug Safety, 1990
- 5-Hydroxytryptamine and its putative aetiological involvement in migraine.Published by Emerald Publishing ,1989
- Spontaneous reporting of adverse drug reactions. I: the data.British Journal of Clinical Pharmacology, 1988